These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

156 related articles for article (PubMed ID: 38733307)

  • 21. Crohn's-like clinical and pathological manifestations of giant inflammatory polyposis in IBD: a potential diagnostic pitfall.
    Naymagon S; Mikulasovich M; Gui X; Ullman TA; Harpaz N
    J Crohns Colitis; 2014 Jul; 8(7):635-40. PubMed ID: 24368253
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Epidemiological, Clinical, Patient-Reported and Economic Burden of Inflammatory Bowel Disease (Ulcerative colitis and Crohn's disease) in Spain: A Systematic Review.
    Barreiro-de Acosta M; Molero A; Artime E; Díaz-Cerezo S; Lizán L; de Paz HD; Martín-Arranz MD
    Adv Ther; 2023 May; 40(5):1975-2014. PubMed ID: 36928496
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Selecting End Points for Disease-Modification Trials in Inflammatory Bowel Disease: the SPIRIT Consensus From the IOIBD.
    Le Berre C; Peyrin-Biroulet L;
    Gastroenterology; 2021 Apr; 160(5):1452-1460.e21. PubMed ID: 33421515
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Burden of Fatigue Among Patients with Ulcerative Colitis and Crohn's Disease: Results from a Global Survey of Patients and Gastroenterologists.
    Regueiro M; Hunter T; Lukanova R; Shan M; Wild R; Knight H; Bannikoppa P; Naegeli AN
    Adv Ther; 2023 Feb; 40(2):474-488. PubMed ID: 36370288
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Estimation of quality of life in Cypriot patients with inflammatory bowel disease.
    Tsoukka M; Jelastopulu E; Lavranos G; Charalambous G
    World J Gastroenterol; 2017 Jan; 23(1):121-126. PubMed ID: 28104987
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Disease activity, steroid use and extraintestinal manifestation are associated with increased disability in patients with inflammatory bowel disease using the inflammatory bowel disease disability index: a cross-sectional multicentre cohort study.
    Lo B; Julsgaard M; Vester-Andersen MK; Vind I; Burisch J
    Eur J Gastroenterol Hepatol; 2018 Oct; 30(10):1130-1136. PubMed ID: 29979218
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Impact of obesity on disease activity and disease outcome in inflammatory bowel disease: Results from the Swiss inflammatory bowel disease cohort.
    Greuter T; Porchet F; Braga-Neto MB; Rossel JB; Biedermann L; Schreiner P; Scharl M; Schoepfer AM; Safroneeva E; Straumann A; Rogler G; Vavricka SR
    United European Gastroenterol J; 2020 Dec; 8(10):1196-1207. PubMed ID: 33276710
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Real-World Persistence of Ustekinumab in the Treatment of Inflammatory Bowel Disease.
    Bressler B; Jones J; In TSH; Lan T; Iconaru C; Marshall JK
    Adv Ther; 2023 Oct; 40(10):4421-4439. PubMed ID: 37507652
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Clinical presentation of Crohn's, ulcerative colitis, and indeterminate colitis: Symptoms, extraintestinal manifestations, and disease phenotypes.
    Yu YR; Rodriguez JR
    Semin Pediatr Surg; 2017 Dec; 26(6):349-355. PubMed ID: 29126502
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Health-related quality of life aspects of the 'Periodontitis prevalence in ulcerative colitis and Crohn's disease' (PPCC) cohort.
    Bertl K; Tsakos G; Pandis N; Bogren A; Burisch J; Stavropoulos A
    J Clin Periodontol; 2023 Dec; 50(12):1601-1620. PubMed ID: 37670508
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Ulcerative Colitis and Crohn's Disease Have Similar Burden and Goals for Treatment.
    Le Berre C; Ananthakrishnan AN; Danese S; Singh S; Peyrin-Biroulet L
    Clin Gastroenterol Hepatol; 2020 Jan; 18(1):14-23. PubMed ID: 31301452
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Worldwide incidence and prevalence of inflammatory bowel disease in the 21st century: a systematic review of population-based studies.
    Ng SC; Shi HY; Hamidi N; Underwood FE; Tang W; Benchimol EI; Panaccione R; Ghosh S; Wu JCY; Chan FKL; Sung JJY; Kaplan GG
    Lancet; 2017 Dec; 390(10114):2769-2778. PubMed ID: 29050646
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Clinical status, psychosocial impairments, medical treatment and health care costs for patients with inflammatory bowel disease (IBD) in Germany: an online IBD registry.
    Bokemeyer B; Hardt J; Hüppe D; Prenzler A; Conrad S; Düffelmeyer M; Hartmann P; Hoffstadt M; Klugmann T; Schmidt C; Weismüller J; Mittendorf T; Raspe H
    J Crohns Colitis; 2013 Jun; 7(5):355-68. PubMed ID: 22503168
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The Prevalence of Inflammatory Bowel Disease in Greenland.
    Gantzel RH; Vesterdal JD; Haase AM; Petersen AJ; Grønbæk H; Pedersen ML
    Inflamm Bowel Dis; 2023 Dec; 29(12):1879-1885. PubMed ID: 36702537
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Clinical features of ulcerative colitis and Crohn's disease in Turkey.
    Ozin Y; Kilic MZ; Nadir I; Cakal B; Disibeyaz S; Arhan M; Dagli U; Tunc B; Ulker A; Sahin B
    J Gastrointestin Liver Dis; 2009 Jun; 18(2):157-62. PubMed ID: 19565044
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Health-care costs of inflammatory bowel disease in a pan-European, community-based, inception cohort during 5 years of follow-up: a population-based study.
    Burisch J; Vardi H; Schwartz D; Friger M; Kiudelis G; Kupčinskas J; Fumery M; Gower-Rousseau C; Lakatos L; Lakatos PL; D'Incà R; Sartini A; Valpiani D; Giannotta M; Arebi N; Duricova D; Bortlik M; Chetcuti Zammit S; Ellul P; Pedersen N; Kjeldsen J; Midjord JMM; Nielsen KR; Winther Andersen K; Andersen V; Katsanos KH; Christodoulou DK; Domislovic V; Krznaric Z; Sebastian S; Oksanen P; Collin P; Barros L; Magro F; Salupere R; Kievit HAL; Goldis A; Kaimakliotis IP; Dahlerup JF; Eriksson C; Halfvarson J; Fernandez A; Hernandez V; Turcan S; Belousova E; Langholz E; Munkholm P; Odes S;
    Lancet Gastroenterol Hepatol; 2020 May; 5(5):454-464. PubMed ID: 32061322
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Fistulizing pattern in Crohn's disease and pancolitis in ulcerative colitis are independent risk factors for cancer: a single-center cohort study.
    Biancone L; Zuzzi S; Ranieri M; Petruzziello C; Calabrese E; Onali S; Ascolani M; Zorzi F; Condino G; Iacobelli S; Pallone F
    J Crohns Colitis; 2012 Jun; 6(5):578-87. PubMed ID: 22398047
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Incidence and initial disease course of inflammatory bowel diseases in 2011 in Europe and Australia: results of the 2011 ECCO-EpiCom inception cohort.
    Vegh Z; Burisch J; Pedersen N; Kaimakliotis I; Duricova D; Bortlik M; Avnstrøm S; Vinding KK; Olsen J; Nielsen KR; Katsanos KH; Tsianos EV; Lakatos L; Schwartz D; Odes S; Lupinacci G; De Padova A; Jonaitis L; Kupcinskas L; Turcan S; Tighineanu O; Mihu I; Barros LF; Magro F; Lazar D; Goldis A; Fernandez A; Hernandez V; Niewiadomski O; Bell S; Langholz E; Munkholm P; Lakatos PL;
    J Crohns Colitis; 2014 Nov; 8(11):1506-15. PubMed ID: 24998983
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Association between inflammatory bowel disease and subsequent depression or anxiety disorders - A retrospective cohort study of 31,728 outpatients.
    Roderburg C; Yaqubi K; Konrad M; May P; Luedde T; Kostev K; Loosen SH
    J Psychiatr Res; 2024 Jan; 169():231-237. PubMed ID: 38048672
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Clinical course during the 1st year after diagnosis in ulcerative colitis and Crohn's disease. Results of a large, prospective population-based study in southeastern Norway, 1990-93.
    Moum B; Ekbom A; Vatn MH; Aadland E; Sauar J; Lygren I; Schulz T; Stray N; Fausa O
    Scand J Gastroenterol; 1997 Oct; 32(10):1005-12. PubMed ID: 9361173
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.